Renalys eyes Japanese Filspari approval on Phase III IgA nephropathy win
Renalys will now submit a NDA to Japanese regulators for Filspari.
28 November 2025
28 November 2025
Renalys will now submit a NDA to Japanese regulators for Filspari.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.